JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267067

Human APOL2 knockout A549 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

APOL2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 5 bp deletion in exon 4 and 8 bp deletion in exon 4.

View Alternative Names

9830006J20Rik, APOL2_HUMAN, ApoL-II, Apol8, Apolipoprotein L 2, Apolipoprotein L-II

2 Images
Sanger Sequencing - Human APOL2 knockout A549 cell line (AB267067)
  • Sanger seq

Unknown

Sanger Sequencing - Human APOL2 knockout A549 cell line (AB267067)

Allele-1 : 5 bp deletion in exon4

Sanger Sequencing - Human APOL2 knockout A549 cell line (AB267067)
  • Sanger seq

Unknown

Sanger Sequencing - Human APOL2 knockout A549 cell line (AB267067)

Allele-2 : 8 bp deletion in exon 4.

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 5 bp deletion in exon 4 and 8 bp deletion in exon 4

Disease

Carcinoma

Product details

Recommended control: Human wild-type A549 cell line (ab255450). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267067-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267067 Human APOL2 knockout A549 cell line", "number":"AB267067-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267067-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267067 Human APOL2 knockout A549 cell line", "number":"AB267067-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
APOL2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium

F-12K + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

APOL2 also known as Apolipoprotein L2 is a protein with molecular mass about 38 kDa. This protein belongs to the apolipoprotein L family and shows expression in various tissues including the pancreas lung and placenta. APOL2 contains lipid-binding domains that enable it to interact with lipids in cellular membranes. It involves in lipid metabolism by aiding the transport of lipids through intracellular compartments.
Biological function summary

APOL2 contributes to lipid trafficking and cellular lipid homeostasis. It plays a role in the formation of lipid droplets within cells significant for energy storage and regulation. APOL2 does not function alone but often acts in coordination with other proteins involved in lipid metabolism including members of its own family. This association through protein complexes allows for efficient regulation of lipid movement and storage in cells.

Pathways

Several important pathways intersect with APOL2's functions. It participates in the lipid metabolism pathway which affects energy balance within cells. Another pathway where APOL2 plays a role is the inflammatory response pathway as its expression can influence the response to inflammatory signals. APOL2 shows functional connections with other apolipoprotein family members such as APOL1 through these pathways helping to maintain cellular biochemical equilibrium.

APOL2 relates to cancer and cardiovascular diseases. Aberrant expression of APOL2 can potentially influence cancer progression by impacting cellular lipid metabolism contributing to tumor growth. In cardiovascular diseases its role in lipid metabolism correlates with the regulation of blood lipid levels affecting cardiovascular health. Notably APOL2's function in cardiovascular diseases may interact with APOL1 which has known links to kidney-related disorders and cardiovascular risk factors.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com